NCT06867159

Brief Summary

Comparison of effects of autogenic inhibition and reciprocal inhibition muscle energy techniques on iliotibial band syndrome

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 10, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

11 months

First QC Date

March 4, 2025

Last Update Submit

March 4, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain severity

    Pain will be assessed using Numeric Pain Rating Scale (NPRS),

    2 weeks

  • Range of motion

    Hip range of motion (ROM) will be assessed using goniometer

    2 weeks

  • Functional status of lower limb

    Lower extremity function will be assessed using Lower Extremity Functional Scale (LEFS)

    2 weeks

Study Arms (2)

Autogenic Inhibition (AI) MET Group

EXPERIMENTAL

Autogenic Inhibition (AI) MET (Post Facilitation Stretch) 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.

Procedure: Autogenic Inhibition (AI) MET (Post Facilitation Stretch)

Reciprocal Inhibition (RI) MET Group

EXPERIMENTAL

Reciprocal Inhibition (RI) MET 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.

Procedure: Reciprocal Inhibition (RI) MET

Interventions

Autogenic Inhibition (AI) MET (Post Facilitation Stretch) 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.

Autogenic Inhibition (AI) MET Group

Reciprocal Inhibition (RI) MET 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.

Reciprocal Inhibition (RI) MET Group

Eligibility Criteria

Age19 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both male and female participants
  • Age : 19-45years (8)
  • Lateral knee pain (\>3 months)
  • Tenderness over lateral femoral condyle
  • Positive Flexibility Tests
  • Modified Ober's test (9)
  • Length assessment of Tensor Fasciae Latae and Iliotibial Band (10)
  • Positive Pain Provocation Tests
  • Renne's test
  • Noble's Compression test (11) \*(individuals with 3 positive tests out of above mentioned 4 tests will be included)

You may not qualify if:

  • Recent lower limb or pelvic girdle surgery within the past 3 months
  • Lower limb fractures or trauma within the past year.
  • Multiple lower limb surgeries (\>2)
  • Presence of any structural or postural disorders (kyphosis or severe scoliosis)
  • Neurological disorders
  • Hip and knee Osteoarthritis
  • Rheumatoid Arthritis
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University College of Physcial Therapy

Rawalpindi, Punjab Province, 46000, Pakistan

RECRUITING

MeSH Terms

Conditions

Iliotibial Band Syndrome

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and InjuriesCumulative Trauma DisordersSprains and Strains

Central Study Contacts

Rida Ishtiaq, MS-MSKPT*

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
It will be a single blinded RCT in which assessor will be blinded to the group allocation of participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2025

First Posted

March 10, 2025

Study Start

July 15, 2024

Primary Completion

June 15, 2025

Study Completion

July 15, 2025

Last Updated

March 10, 2025

Record last verified: 2025-03

Locations